✦ LIBER ✦

Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial

✍ Scribed by Diamant, Michaela; Van Gaal, Luc; Guerci, Bruno; Stranks, Stephen; Han, Jenny; Malloy, Jaret; Boardman, Marilyn K; Trautmann, Michael E

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Once weekly exenatide compared with insu

✍ Michaela Diamant; Luc Van Gaal; Stephen Stranks; Justin Northrup; Dachuang Cao; 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 496 KB

Exenatide once weekly versus twice daily

✍ Daniel J Drucker; John B Buse; Kristin Taylor; David M Kendall; Michael Trautman 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 276 KB

Once-weekly dulaglutide versus once-dail

✍ Dungan, Kathleen M; Povedano, Santiago Tofé; Forst, Thomas; González, José G Gon 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 535 KB

Efficacy and safety of exenatide once we

✍ Richard M Bergenstal; Carol Wysham; Leigh MacConell; Jaret Malloy; Brandon Walsh 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 399 KB

Insulin degludec, an ultra-long-acting b

✍ Bernard Zinman; Greg Fulcher; Paturi V Rao; Nihal Thomas; Lars A Endahl; Thue Jo 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 203 KB

Efficacy and safety of insulin degludec

✍ Zinman, Bernard; DeVries, J Hans; Bode, Bruce; Russell-Jones, David; Leiter, Law 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 337 KB